IN A NUTSHELL:
LAURA DEMING, an 18-year-old venture capitalist and Thiel Fellow, will tell us how she found the next emerging market through her passion for extending the human healthspan.
Currently a Forbes 30 under 30 star and partner at The Longevity Fund, Laura has wanted to cure aging since the age of 8. After years working on nematode longevity at the UCSF graduate school, Laura matriculated at MIT at 14 to work on artificial organogenesis and bone aging, and is now based in San Francisco, working to find and fund therapies to extend the human healthspan. She has also recently become a Board Observer at Navitor Pharmaceuticals.